VRTX logo
Vertex Pharmaceuticals Incorporated(VRTX)
Last print unknown agoAbout this dataData status
$501.95▲2.21 (0.44%)Stale · unknown oldEarnings · Nov 2

VRTX Property Plant Equipment Net

$3.33BQuarterly · USD

Period ending:

VRTX FY PP&E (Net)USD
VRTX FY PP&E (Net)1990-12-31: $4.40M1991-12-31: $5.00M1992-12-31: $6.90M1993-12-31: $7.70M1994-12-31: $8.50M1995-12-31: $7.80M1996-12-31: $8.70M1997-12-31: $11.10M1998-12-31: $14.50M1999-12-31: $24.48M2000-12-31: $43.96M2001-12-31: $80.38M2002-12-31: $95.99M2003-12-31: $80.08M2004-12-31: $64.23M2005-12-31: $54.53M2006-12-31: $61.54M2007-12-31: $66.51M2008-12-31: $68.33M2009-12-31: $62.28M2010-12-31: $72.33M2011-12-31: $133.18M2012-12-31: $433.61M2013-12-31: $696.91M2014-12-31: $715.81M2015-12-31: $697.72M2016-12-31: $698.36M2017-12-31: $789.44M2018-12-31: $812.01M2019-12-31: $833.28M2020-12-31: $1.28B2021-12-31: $1.42B2022-12-31: $1.46B2023-12-31: $1.45B2024-12-31: $2.58B2025-12-31: $3.08B$3.08B$0.00
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

VRTX property plant equipment net history

Net property, plant, and equipment. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Vertex Pharmaceuticals Property Plant Equipment Net — Annual fiscal periods (USD)
Period endingProperty Plant Equipment Net (USD)
3,083,000,000
2,584,600,000
1,452,900,000
1,455,800,000
1,424,400,000
1,284,100,000
833,282,000
812,005,000
789,437,000
698,362,000
697,715,000
715,812,000
696,911,000
433,609,000
133,176,000
72,333,000
62,279,000
68,331,000
66,509,000
61,535,000
54,533,000
64,225,000
80,083,000
95,991,000
80,377,000
43,961,000
24,480,000
14,500,000
11,100,000
8,700,000
7,800,000
8,500,000
7,700,000
6,900,000
5,000,000
4,400,000

Compare property plant equipment net

All VRTX financial metrics · VRTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.